POCT Market in the US 2015-2019

アメリカのPOCT(臨床現場即時検査)市場

◆タイトル:POCT Market in the US 2015-2019
◆商品コード:IRTNTR7799
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年11月18日
◆ページ数:70
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:米国
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、アメリカのPOCT(臨床現場即時検査)市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、アメリカのPOCT(臨床現場即時検査)市場規模及び予測、用途別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About POCT
POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients’ quality of life.

The methods of POCT include meters or monitors and strips. The POCT diagnostic devices are of two types: bedside and near-bedside monitoring devices. The bedside POCT devices are small and offer mobility whereas the near-bedside POCT devices are large and complex. These devices are used to test cardiac biomarkers, blood coagulation, platelet function, HIV, hemoglobin concentration, ad five-part differential blood count.

Technavio’s analysts forecast the POCT market in the US to grow at a CAGR of 5.88% over the period 2014-2019.

[Covered in this report]
The report covers the current scenario and the growth prospects of the POCT market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of POCT diagnostic devices. The market is segmented based on application:
Blood glucose testing
Infectious disease testing
Cardiac markers testing
Pregnancy and fertility testing
Blood gas/electrolyte testing
Tumour markers testing
Urinalysis testing
Cholesterol testing

Technavio’s report, POCT Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the key vendors in the market. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

[Key vendors]
Abbott diagnostics
Alere
Roche Diagnostics
Siemens Diagnostics

[Other prominent vendors]
Abaxis
Acon Laboratories
Avioq
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
Hologic
i-Sens
Landwind Medical
Mindray
Nipro Diagnostics
Randox Laboratories
Span Diagnostics
Sysmex
Thermo Fisher Scientific
Trivitron Healthcare
URIT

[Market driver]
North America free trade agreement
For a full, detailed list, view our report

[Market challenge]
Limitation of POCT products
For a full, detailed list, view our report

[Market trend]
Key role of USAMRIID
For a full, detailed list, view our report

[Key questions answered in this report]
What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview

PART 06: Healthcare reform in US
Introduction of PPACA
Five forces analysis

PART 07: Market segmentation by application
Blood glucose testing market in US
Infectious disease testing market in US
Cardiac marker testing market in US
Coagulation testing market in US
Pregnancy and fertility testing market in US
Blood gas/electrolyte testing market in US
Tumor marker testing market in US
Urinalysis testing market in US
Cholesterol testing market in US

PART 08: Market drivers
Influence of NAFTA
Demand for rapid and automated diagnostics
POCT at home
Technological innovations
Collaborations and M&A to enhance POCT technology

PART 09: Impact of drivers

PART 10: Market challenges
Issues of intellectual property rights
Threat of low-cost products
Product recalls

PART 11: Impact of drivers and challenges

PART 12: Market trends
Shift toward patient-centered model
Low-cost microfluidic devices for POCT
Growing popularity of portable POCT products
Role of USAMRIID

PART 13: Vendor landscape
Competitive scenario
Abbott Diagnostics
Alere
Roche Diagnostics
Siemens Diagnostics
Other prominent vendors

PART 14: Key vendor analysis
Abbott Diagnostics
Alere
Roche Diagnostics
Siemens Healthcare

PART 15: Appendix
List of abbreviations

PART 16: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: POCT market in US 2014-2019 ($ millions)
Exhibit 03: PPACA benefits for US citizens
Exhibit 04: Comparison of US healthcare provision pre and post reform
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of POCT market in US by application
Exhibit 07: Blood glucose testing market in US 2014-2019 ($ millions)
Exhibit 08: Infectious disease testing market in US 2014-2019 ($ millions)
Exhibit 09: Cardiac marker testing market in US 2014-2019 ($ millions)
Exhibit 10: Coagulation testing market in US 2014-2019 ($ millions)
Exhibit 11: Pregnancy and fertility testing market in US 2014-2019 ($ millions)
Exhibit 12: Blood gas/electrolyte testing market in US 2014-2019 ($ millions)
Exhibit 13: Tumor marker testing market in US 2014-2019 ($ millions)
Exhibit 14: Urinalysis testing market in US 2014-2019 ($ millions)
Exhibit 15: Cholesterol testing market in US 2014-2019 ($ millions)
Exhibit 16: Segmentation of POCT market in US by application 2014POCT market in US by application 2014
Exhibit 17: Impact of drivers
Exhibit 18: Impact of drivers and challenges
Exhibit 19: Abbott Diagnostics: Key takeaways
Exhibit 20: Alere: Key takeaways
Exhibit 21: Roche Diagnostics: Key takeaways
Exhibit 22: Siemens Diagnostics: Key takeaways
Exhibit 23: Abbott Diagnostics: Key business offerings
Exhibit 24: Alere: Business Segmentation by revenue 2014
Exhibit 25: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 26: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 29: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 30: Siemens Healthcare: Business segmentation
Exhibit 31: Siemens Healthcare: Geographical segmentation by revenue 2014



【掲載企業】

Abbott Diagnostics, Alere, Roche Diagnostics, Siemens, Abaxis, Acon Laboratories, Avioq, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, Hologic, Thermo Fisher Scientific, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Sysmex, Trivitron Healthcare, URIT.

【資料のキーワード】

POCT(臨床現場即時検査)、アメリカ、POC検査、血糖検査、感染症検査、心疾患マーカー、凝固検査

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[アメリカのPOCT(臨床現場即時検査)市場] (POCT Market in the US 2015-2019 / IRTNTR7799)販売に関する免責事項
[アメリカのPOCT(臨床現場即時検査)市場] (POCT Market in the US 2015-2019 / IRTNTR7799)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆